MEHRAD ABEDI, M.D.

SACRAMENTO, CA

Research Active
Internal Medicine - Hematology & Oncology NPI registered 21+ years 50 publications 2025 – 2026 NPI: 1467459222
MiceArtificial IntelligenceAntioxidantsDeep LearningDrug Resistance, NeoplasmEcosystemBrain NeoplasmsExosomesNanoparticlesIranGlioblastomaHistory, 21st CenturyBlood-Brain BarrierPhytochemicalsGrassland

Practice Location

4501 X ST STE 3016
SACRAMENTO, CA 95817-2229

Phone: (916) 734-5981

What does MEHRAD ABEDI research?

Dr. Abedi studies several critical areas in medicine, primarily targeting autoimmune diseases, patient safety in healthcare settings, and cellular control mechanisms. For instance, his research on CAR T cell therapy explores how this cutting-edge treatment can help patients with pemphigus vulgaris, an autoimmune disorder, even without the conventional lymphodepletion preparation. He also investigates the effectiveness of treatment plans for conditions like chronic obstructive pulmonary disease (COPD) and the outcomes of surgeries to improve speech in patients with cleft palates. Furthermore, Dr. Abedi is involved in understanding how workplace injuries affect recovery and return-to-work outcomes, delving into the factors that improve or hinder patients' progress.

Key findings

  • In a trial of CAR T cell therapy for pemphigus vulgaris, all four patients showed significant improvement, with no serious complications reported.
  • Only 57% of patient safety incident reports in Australian hospitals fully described the events leading to safety issues, highlighting the need for better investigation methods.
  • In a study on returning to work post-injury, 88% of participants managed to return to their jobs within a year, typically with modifications.
  • Only around 26% of patients achieved normal speech after secondary surgery for velopharyngeal insufficiency, with younger patients and those with less severe conditions having better outcomes.
  • The use of autologous CD34+ stem cells in treating central retinal vein occlusion resulted in no significant vision loss, showing it as a safe treatment option.

Frequently asked questions

Does Dr. Abedi study autoimmune diseases?
Yes, Dr. Abedi researches treatments for autoimmune diseases, including pemphigus vulgaris, using innovative therapies like CAR T cell therapy.
What treatments has Dr. Abedi researched for respiratory issues?
Dr. Abedi has examined the impact of pulmonary rehabilitation on patients with chronic obstructive pulmonary disease (COPD) and its potential effects on cognitive improvement.
Is Dr. Abedi's work relevant to patients with cleft palates?
Yes, he studies surgical outcomes for individuals with cleft palates, helping to identify factors that affect recovery and speech improvement.
How does Dr. Abedi contribute to patient safety in healthcare?
He analyzes patient safety incident reports, aiming to improve the quality of investigations following safety issues in hospitals.
What is Dr. Abedi's research on returning to work after injuries?
His studies focus on how individuals who have suffered road traffic injuries can successfully return to work, identifying key predictors for better outcomes.

Publications in plain English

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

2026

Blood advances

Tuscano JM, Othman T, Frankel P, Ruel C, Poh C +20 more

Plain English
This study looked at the combination of two drugs, blinatumomab and lenalidomide, for treating patients with relapsed or hard-to-treat B-cell lymphoma. Out of 34 patients treated, 80% had some positive response to the therapy, with 70% achieving complete remission, and 24% staying cancer-free for more than two years. This research is significant as it shows that this drug combination could offer a new treatment option for patients who have tried multiple other therapies with limited success. Who this helps: This helps patients with relapsed or refractory B-cell lymphoma.

PubMed

Fabrication of ferulic acid-decorated ZnO nanoparticles in a chitosan matrix: A bioactive powder for wound management.

2026

International journal of biological macromolecules

Zomorrodian H, Abedi A, Arbabi M, Gholampour R, Abedi M +3 more

Plain English
This study developed a new antibacterial wound dressing using zinc oxide nanoparticles surrounded by a blend of natural substances like chitosan and collagen. The researchers found that this dressing released healing compounds steadily for 48 hours and worked better than existing options, helping wounds heal faster in diabetic rats. This is important because it offers a promising solution for patients with challenging wounds that are slow to heal. Who this helps: Patients with chronic or hard-to-heal wounds.

PubMed

PEGASUS: Unlocking Polarity in Cell-Permeable Cyclic Peptides Using AI Models Built on Massively Parallel Biological Assays.

2026

Journal of medicinal chemistry

Baker C, Acquah FA, Chivukula LG, Wu L, Philippe-Venec L +6 more

Plain English
Researchers studied how to improve the ability of cyclic peptides, which are potential new medications, to cross cell membranes. They developed an AI model called PEGASUS that can predict which peptide designs will be successful in this area. The results showed that they could create cyclic peptides with more than two polar or ionizable parts, leading to better permeability through cell membranes, which is crucial for their effectiveness as therapies. Who this helps: This helps drug developers and patients seeking new oral medications.

PubMed

Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

2026

Haematologica

Jabbour E, Sandhu KS, Shaughnessy P, Logan AC, Abedi M +15 more

Plain English
This research studied a new treatment called obecabtagene autoleucel (obe-cel) for adult patients with a tough form of leukemia called relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL). The findings showed that using a method that adjusts the dose based on how much cancer is present in the body (called tumor burden) helped reduce severe side effects, with only 2% of patients experiencing serious cytokine release syndrome and 3% facing severe neurotoxicity in the low tumor burden group. Overall, 85% of patients in the low tumor burden group achieved remission, compared to 73% in the high tumor burden group, indicating that this innovative dosing strategy keeps the treatment effective while causing fewer harmful effects. Who this helps: This benefits patients with relapsed/refractory B-cell acute lymphoblastic leukemia and their doctors.

PubMed

A hierarchically engineered FeCoP/CuS flake-like clustered heterostructure with benchmark-level trifunctional electrocatalytic activity and long-term durability in challenging alkaline systems.

2026

Nanoscale

Abedi M, Rezaee S, Shahrokhian S

Plain English
This study looked at creating a new type of electrocatalyst that can efficiently help with three important reactions in energy systems: hydrogen production, oxygen production, and oxygen reduction. The researchers developed a structure using copper sulfide (CuS) and iron-cobalt phosphide (FeCoP), which showed excellent performance—requiring only 69 millivolts for hydrogen production and 147 millivolts for oxygen production. This is significant because it offers a low-cost and durable solution for energy conversion, operating efficiently in both regular alkaline environments and seawater. Who this helps: This benefits researchers and developers working on renewable energy technologies, including hydrogen fuel sources and batteries.

PubMed

Investigating the Role of Pulmonary Rehabilitation on Cognition in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review.

2026

Journal of cardiopulmonary rehabilitation and prevention

Dibajnia P, Abedi M, Mirsaeidi H, Rezaei M, Rahmani Rasa A +1 more

Plain English
This study looked at how pulmonary rehabilitation (a program that helps people with chronic obstructive pulmonary disease, or COPD, improve their breathing and overall health) affects brain function. It analyzed 10 different studies involving a total of 346 COPD patients and found that pulmonary rehabilitation may improve thinking skills, especially when paired with cognitive training. Understanding these benefits is important because it can lead to better treatment plans for people with COPD, aiming to enhance both their physical and mental health. Who this helps: Patients with chronic obstructive pulmonary disease.

PubMed

Comparative efficacy of three mismatched enterotropic Newcastle disease vaccines against genotype VII challenge in chickens.

2026

Tropical animal health and production

Abedi M, Hassanzadeh M, Bashashati M, Yousefi AR, Abdoshah M

Plain English
This study looked at how well three different Newcastle disease vaccines worked in chickens challenged with a specific harmful virus (genotype VII). The researchers found that the E2 vaccine was particularly effective, providing full protection for 100% of the vaccinated chickens, while the control group had no protection at all. This is important because Newcastle disease can cause major losses in poultry farming, and effective vaccines can help keep chickens safe from this easily spread disease. Who this helps: This research benefits poultry farmers and the overall poultry industry.

PubMed

Abiotic and biotic controls of non-native perennial plant success in drylands.

2026

Nature ecology & evolution

Rahmanian S, Eisenhauer N, Huang Y, Hejda M, Pyšek P +112 more

Plain English
This study looked at how non-native plants thrive in dry, arid areas compared to native plants. Researchers found that non-native plants tend to grow faster and do better in areas with more grazing animals and richer soil. Specifically, at sites with high grazing pressure, the presence of non-native plants increased, while native plants diminished. Understanding these patterns is crucial for managing land and preserving local plant and animal diversity. Who this helps: This helps land managers and conservationists working in dry environments.

PubMed

Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility.

2026

Ophthalmology science

Park SS, McCormack J, Salazar D, King JS, Salvador M +10 more

Plain English
This study looked at the safety and feasibility of using a type of stem cell, known as autologous CD34+ bone marrow stem cells, to treat vision loss caused by central retinal vein occlusion (CRVO). Sixteen participants received injections of these stem cells, with an average of about 4.3 million cells per eye, and the results showed that the treatment was generally safe, with most participants experiencing only minor issues like new floaters (93% of cases). Importantly, no participants experienced significant vision loss after the treatment. Who this helps: This research benefits patients with vision loss from central retinal vein occlusion by exploring a new potential treatment option.

PubMed

Model development of a multivariable prediction model for long-term work-related neck disability among high risk occupations: A prospective cohort study.

2026

Musculoskeletal science & practice

Xie Y, Abedi M, Chen L, Johnson V, Bisset LM +1 more

Plain English
This study focused on predicting long-term neck disability in workers, particularly sonographers in Australia and New Zealand. Researchers developed two models to assess risk: one more complex with 18 factors and a simpler one with 5, which were both effective in identifying those likely to experience severe neck problems after 12 months. The findings show that personal beliefs about pain and how neck pain affects daily life are key indicators of potential disability, rather than simply workplace ergonomics. Who this helps: This helps workers with neck pain and healthcare providers by identifying those at high risk of long-term disability.

PubMed

Checklist of edaphic endemic plants in northeastern Iran: diversity, distribution patterns, and conservation.

2026

Scientific reports

Rahmaninia H, Ejtehadi H, Memariani F, Abedi M, Palacio S

Plain English
This research looked at unique plants that grow in specific types of soil in northeastern Iran and southern Turkmenistan. It identified 71 different plant species, including 35 that are only found in that area, and classified them based on their soil preferences. The findings revealed that while some plants are stable in their habitats, others that depend solely on certain soils are at risk, highlighting the need for conservation efforts as environmental changes continue. Who this helps: This benefits conservationists and environmentalists working to protect plant diversity.

PubMed

The past, present and future of de novo protein design.

2026

Nature

Yang W, Wang S, Lee GR, Zhang JZ, Courbet A +19 more

Plain English
This paper examines how advancements in deep learning are transforming protein design from a game of chance to a precise science. Researchers have made significant progress in creating new proteins and tools, with the potential to design effective protein-based medications and materials. Over the next five to ten years, we expect to see innovative protein systems that could lead to breakthroughs in medical treatments and environmental solutions. Who this helps: This benefits patients and researchers in medicine and biotechnology.

PubMed

Trajectory and Predictors of Return-to-Work Outcomes for People After a Road Traffic Injury: A Prospective Cohort Study.

2026

Journal of occupational rehabilitation

Abedi M, Aplin T, Gane E, Johnston V

Plain English
This study looked at how people who were injured in road traffic accidents return to work over a year and what factors affect their ability to return. It found that 88% of participants returned to work within 12 months, usually with changes to their job, and that the average number of days they couldn't work due to their injuries was 48. Key factors that made a difference included having a less severe injury, being younger, and having a higher income before the accident. Who this helps: This benefits injured workers and rehabilitation professionals.

PubMed

De novo design of a macrocycle induced dimerization system for cellular control.

2026

bioRxiv : the preprint server for biology

Hanna S, Salveson PJ, Wicky B, Kennedy MA, Hicks DR +10 more

Plain English
This study focused on creating a system that allows scientists to control protein functions in cells using a specially designed molecule called a macrocycle. The researchers designed a specific macrocyclic peptide and a protein that works together, binding with a strong affinity of 36 nanomolar. This development is significant because it enables precise manipulation of cellular processes, which can lead to advances in medical treatments and research. Who this helps: This benefits researchers and doctors looking to understand and control cellular activities for better therapies.

PubMed

Prognostic Factors Influencing Speech Outcomes Following Secondary Palatal Surgery with Intravelar Veloplasty (IVVP) in Individuals with Velopharyngeal Insufficiency.

2026

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association

Abedi M, Rezaei P, Derakhshandeh F, Hosseinabad HH

Plain English
This study looked at how factors like age, the severity of speech issues, and the type of cleft impact the outcomes of a specific surgery designed to improve speech in patients with velopharyngeal insufficiency (VPI) after a cleft palate. It found that only about 26% of patients had normal speech after surgery, but younger patients, those with less severe symptoms, and those with certain types of clefts were more likely to do better. Understanding these factors can help anticipate which patients will benefit most from this surgery and who might need more procedures in the future. Who this helps: This helps patients with cleft palates and their families by guiding treatment decisions.

PubMed

De novo design of a macrocycle-induced dimerization system for cellular control.

2026

Nature communications

Hanna S, Salveson PJ, Wicky B, Kennedy MA, Hicks DR +10 more

Plain English
This research focused on creating a system to control proteins in cells by using a specially designed molecule and protein pair. They found that their newly designed macrocyclic peptide binds effectively to the protein, with a strong binding measure of 36 nanomolar, and confirmed that their design worked as intended in laboratory tests involving living cells, enabling controlled gene expression. This is important because it allows for precise manipulation of cellular functions, which could improve treatments and studies in cell biology and medicine. Who this helps: Patients and researchers working on targeted therapies and cellular biology.

PubMed

Assessing the quality of patient safety incident investigation reports.

2026

International journal for quality in health care : journal of the International Society for Quality in Health Care

Bowditch L, Molloy CJ, King B, Abedi M, Jackson S +10 more

Plain English
This study looked at how well Australian hospitals investigate and report on incidents that affect patient safety. Out of 300 reports analyzed, only 57% fully described the events that led to safety issues, and just 4% used observations of healthcare processes to understand what happened better. Improving the quality of these reports is crucial because better investigations can help prevent future incidents and enhance patient safety. Who this helps: This helps patients and healthcare providers by ensuring safer hospital environments.

PubMed

CD19 CAR T Therapy Is Feasible in Patients with Pemphigus Vulgaris Treated Without Lymphodepletion in the RESET-PV Trial.

2026

Blood

Nunez D, Stadanlick J, Furmanak T, Goldenberg J, Choudhary GS +28 more

Plain English
This study looked at how effective a specific CAR T cell therapy (called rese-cel) is for patients with pemphigus vulgaris, an autoimmune disease, when they are not pre-treated with lymphodepletion (LD). The researchers found that all four patients showed improvement in their condition, with their disease scores significantly decreasing. Additionally, the treatment was safe, with only one mild side effect reported and no serious complications. Who this helps: This research benefits patients with pemphigus vulgaris by providing a new and potentially safer treatment option.

PubMed

Severe Treatment-Refractory Macrophage Activation Syndrome: Hemophagocytic Lymphohistiocytosis Presenting With Neurologic Crisis in Systemic Lupus Erythematosus.

2026

Cureus

Rahman Z, Scotto T, Watford S, Woodbeck B, Ali K +3 more

Plain English
This study looked at a 21-year-old woman who developed a severe condition called Macrophage Activation Syndrome (MAS) associated with her systemic lupus erythematosus (SLE), leading to life-threatening inflammation and neurological problems. Despite initial treatments with high-dose steroids and plasma exchange, her condition did not improve, and she eventually required a more aggressive treatment protocol. This highlights how crucial it is for doctors to quickly identify MAS in autoimmune patients, as early and effective treatment can significantly improve patient outcomes. Who this helps: This helps patients with autoimmune diseases and their doctors by improving understanding and treatment of serious complications.

PubMed

The global extent of the grassland biome and implications for the terrestrial carbon sink.

2026

Nature ecology & evolution

MacDougall AS, Vanzant B, Sulik J, Bagchi S, Naidu D +140 more

Plain English
This study looked at how accurately grasslands are mapped around the world and found significant errors, which can affect our understanding of how much carbon is stored in the Earth. It revealed that grasslands actually cover 22.8% of land surfaces, which is about 30.1 million square kilometers, leading to a new estimate of carbon stored in soils at 155.02 petagrams. This matters because more precise mapping of grasslands helps improve climate change strategies and policies related to carbon storage. Who this helps: This benefits policymakers and environmental scientists focused on climate change and carbon management.

PubMed

Motherhood and imprisonment: a typology of mothers' identity after release.

2025

International journal of prison health

Mirhosseini Z, Larijani M, Abedi M

Plain English
This study examined the experiences of 18 Iranian women who have been imprisoned and their identities as mothers after being released. Researchers identified three types of relationships these mothers have with their children: "Terminated motherhood," where the bond is largely broken; "Intensified motherhood," where they strengthen their connection; and "Indifferent and hostile motherhood," where the relationship is at risk of falling apart. The findings highlight the critical need for social and economic support to help mothers reconnect with their children and improve family dynamics. Who this helps: This helps mothers who have been incarcerated and their children.

PubMed

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.

2025

Leukemia

Shah BD, Cassaday RD, Park JH, Houot R, Logan AC +24 more

Plain English
This study examined a treatment called brexucabtagene autoleucel (brexu-cel) for adults with a tough-to-treat blood cancer called B-cell acute lymphoblastic leukemia. After more than three years of follow-up with 78 patients, the treatment led to a 74% rate of complete remission or partial recovery, with an average survival time of about 26 months. Importantly, this treatment worked well for all patients, regardless of their age and past treatments. Who this helps: This study benefits patients suffering from relapsed or refractory B-cell acute lymphoblastic leukemia and their doctors.

PubMed

Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promises.

2025

Pathology, research and practice

Miri H, Rahimzadeh P, Hashemi M, Nabavi N, Aref AR +6 more

Plain English
This research paper looks at using immunotherapy to treat hepatocellular carcinoma (HCC), a serious type of liver cancer that is hard to treat. It discusses how immunotherapy can boost the body's immune system to fight the cancer more effectively, showing promising results from recent clinical trials. For instance, specific drugs have been found to be effective and safe, providing a new avenue for treatment and improving patient outcomes. Who this helps: This helps patients with liver cancer and their doctors looking for more effective treatment options.

PubMed

Caper bush (Capparis spinosa L.) bioactive compounds and antioxidant capacity as affected by adaptation to harsh soils.

2025

Scientific reports

Yousefi E, Abedi M, Aghajanzadeh TA, Moreno DA

Plain English
This study looked at how different types of soil affect the nutritional and health-related qualities of the caper bush, a plant that grows well in tough environments. Researchers found that caper parts from gypsum soil had much higher amounts of beneficial compounds than those from non-gypsum soil; for example, petals from gypsum soil had 2,317.78 mg of total phenolics per kilogram, compared to only 635.06 mg in seeds from non-gypsum soil. This matters because it highlights the caper bush as a valuable food source, rich in health-boosting compounds, particularly in harsh soil conditions. Who this helps: This helps patients and health-conscious consumers looking for nutrient-rich foods.

PubMed

Aerobic exercise training for chronic obstructive pulmonary disease: What is the best regimen to increase heart rate variability?

2025

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Abedi M, Mirtajani SB, Firouzabadi SR, Zahiri R, Mirenayat MS

PubMed

The function of circular RNAs in regulating Wnt/β-catenin signaling: An innovative therapeutic strategy for breast and gynecological cancers.

2025

Pathology, research and practice

Kahkesh S, Hedayati N, Rahimzadeh P, Farahani N, Khoozani MF +7 more

Plain English
This research examines how circular RNAs (circRNAs) interact with a signaling pathway known as Wnt/β-catenin, which is crucial for the growth and spread of breast and gynecological cancers, like cervical, ovarian, and uterine cancers. The study found that circRNAs play a significant role in controlling important cellular functions such as cell growth and death, potentially leading to better treatment options. By focusing on targeting these circRNAs, doctors may enhance diagnostics and improve treatment outcomes for patients suffering from these cancers. Who this helps: This helps patients with breast and gynecological cancers.

PubMed

Therapeutic Effects of Low-Level Laser Therapy on Rat Spinal Cord Injury: Analysis of Inflammatory Markers and Testicular Function.

2025

Journal of lasers in medical sciences

Taheri H, Mosleh HR, Jahanbaz S, Aliaghaei A, Tahmasebinia F +3 more

Plain English
This study looked at how low-level laser therapy could help male rats with spinal cord injuries by reducing inflammation and protecting reproductive health. The researchers found that untreated rats experienced significant declines in sperm count, motility, and viability, along with increased inflammation. In contrast, the rats that received laser therapy showed improvements in these reproductive measures, including a fourfold increase in sperm count (from 14.2 to 48) and reduced inflammation markers. Who this helps: This benefits male patients with spinal cord injuries and their reproductive health.

PubMed

Ingestion of mast cell granules boosts macrophages and drives atypical programming.

2025

The Journal of allergy and clinical immunology

Katsoulis-Dimitriou K, Schmidt J, Roder M, Dudeck J, Philipsen L +18 more

Plain English
This study looked at how mast cells, which release granules during injury or infection, affect macrophages, a type of immune cell. Researchers found that when macrophages take in these granules, it significantly boosts their abilities and changes them in a unique way, making them more effective in fighting infections and repairing tissue. In experiments with both mice and human samples, they discovered that this process enhances macrophage function by mixing features of different types of macrophages, potentially leading to better immune responses. Who this helps: This helps patients with inflammatory conditions, as understanding this mechanism could lead to new treatments.

PubMed

Exosomes beyond stem cells during traumatic brain injury: hype or hope?

2025

Brain injury

Hajinejad M, Abedi M, Sahab Negah S

Plain English
This study looked at stem cell therapy and exosomes, which are tiny particles released by cells, to see how they can be used to treat traumatic brain injuries (TBI). It found that exosomes can address some issues that arise with stem cell therapy, making them a promising option for treatment. The review highlighted the need for more research on how exosomes work and their potential benefits in TBI treatment. Who this helps: This helps patients with traumatic brain injuries and the doctors treating them.

PubMed

Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acids: advances and challenges.

2025

Journal of nanobiotechnology

Sanadgol N, Abedi M, Hashemzaei M, Kamran Z, Khalseh R +2 more

Plain English
This study looked at how exosomes, tiny particles released from cells, can be used to deliver gene therapies directly to the brain, overcoming challenges posed by the blood-brain barrier. The research showed that exosomes are effective at carrying therapeutic genetic material and can significantly improve the delivery of these treatments to brain cells, which is crucial for addressing neurological disorders. These findings could lead to safer and more efficient therapies for conditions affecting the brain. Who this helps: This benefits patients with neurological disorders who may receive better treatment options.

PubMed

Cognitive Effect of Levetiracetam in Patients with Alzheimer's Disease or Mild Cognitive Impairment: A Systematic Review.

2025

Current therapeutic research, clinical and experimental

Mohamadi MH, Bavafa A, Salehi S, Abedi M, Shahabi F +3 more

Plain English
This review looked into how well levetiracetam, a medication typically used for epilepsy, can help improve thinking and memory in people with Alzheimer's disease or mild cognitive impairment. Out of 1,091 studies, only 5 were suitable for review, and among those, 4 showed that patients had significant cognitive improvements after using levetiracetam, while 1 study found no noticeable change. This is important because it indicates that levetiracetam might be a useful treatment option for cognitive issues in Alzheimer’s and mild cognitive impairment patients. Who this helps: Patients with Alzheimer's disease or mild cognitive impairment.

PubMed

The Audiologist's Role in Determining Cochlear Function After Gunshot Injury to the Temporal Bone.

2025

American journal of audiology

Majoue M, Abedi M, Hurley A

Plain English
This study looked at how audiologists can help assess hearing function in patients who have suffered gunshot injuries to their temporal bone, which is a critical area near the ear. The researchers found that using different assessment methods led to varying results in three case studies, indicating that a coordinated effort between audiologists and surgeons is essential for better patient outcomes. This matters because timely and accurate hearing evaluations can significantly improve treatment options and recovery for these patients. Who this helps: This helps patients who have suffered traumatic injuries, particularly those affected by gun violence.

PubMed

Evaluation of Inspiratory Muscle Training Effect Compared With Diaphragmatic Breathing in Respiratory Parameters in Amyotrophic Lateral Sclerosis Patients: A Randomized Controlled Trial.

2025

Medical journal of the Islamic Republic of Iran

Mirenayat MS, Fakharian A, Valizadeh M, Abedi M, Sadeghi S +4 more

Plain English
This study focused on how inspiratory muscle training (IMT) affects breathing in patients with amyotrophic lateral sclerosis (ALS), a condition that often leads to respiratory failure. Researchers tested 22 ALS patients, dividing them into two groups: one group did standard exercises, while the other group did the same plus IMT. After 8 weeks, the group using IMT showed significant improvements in their breathing strength, especially in their maximum inspiratory pressure (PImax), which increased by a notable amount compared to the control group. Who this helps: This benefits ALS patients who struggle with breathing difficulties.

PubMed

Reproductive health programs in women with physical disabilities: A scoping review protocol.

2025

PloS one

Abedi M, Soleymani M, Talebi SS, Motaghi Z

Plain English
This study looked at reproductive health programs specifically for women with physical disabilities, who make up about 15% of people with disabilities of reproductive age. It found that these women are often overlooked in terms of healthcare, which can lead to challenges in managing their sexual and reproductive health. The review aims to gather information on existing programs from 2006 to 2024 to highlight what is working and where there are gaps, helping to improve access to necessary care. Who this helps: This benefits women with physical disabilities, healthcare providers, and policymakers.

PubMed

HeteroMRI: Robust white matter abnormality classification across multi-scanner MRI data.

2025

GigaScience

Abedi M, Shekarchizadeh N, Bazin PL, Scherf N, Lier J +4 more

Plain English
This study focused on improving the analysis of brain MRI scans to detect white matter abnormalities, especially when data comes from different MRI machines. Researchers developed a new method called HeteroMRI, which uses deep learning to classify these MRI images accurately. They found that this method achieved an impressive accuracy of about 93% in identifying abnormalities and showed only minor declines in accuracy even when the amount of data was significantly reduced. Who this helps: This benefits doctors and patients, particularly those affected by rare diseases.

PubMed

Exploration of techniques for the enhancement of latent fingermarks from fired and unfired cartridge cases: a systematic review.

2025

Forensic sciences research

Abedi M, Mabasa C, Mabudusha SA

Plain English
This study looked at different methods for making fingerprint patterns visible on fired and unfired bullet cartridge cases, which is important for solving crimes. It found that the best way to enhance these hidden fingerprints is by using cyanoacrylate fuming first, then gun bluing, and finally a fluorescent dye called basic yellow 40. Understanding which methods work best is crucial because it helps forensic investigators gather evidence that can make a difference in legal cases. Who this helps: This helps forensic scientists and law enforcement working to solve crimes.

PubMed

Nanomedicine solutions for inhibiting anastasis and inducing apoptosis to mitigate relapse in treatment-resistant cancers.

2025

European journal of pharmacology

Hashemi SR, Hosseinpour-Soleimani F, Abedi M, Tajbakhsh A, Nemati MM +3 more

Plain English
This study explored new treatments for cancer that could help overcome the resistance some tumors have to existing therapies. Researchers found that a process called anastasis allows cancer cells to recover from near-death states, making them harder to kill. By using advanced nanoparticles to deliver targeted therapies that disrupt this process, they aim to improve cancer treatment effectiveness while reducing side effects. Who this helps: This benefits cancer patients who struggle with treatment-resistant types of the disease.

PubMed

Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.

2025

Human vaccines & immunotherapeutics

Bota DA, Piccioni DE, Duma CM, Kesari S, Carrillo JA +9 more

Plain English
This study looked at a personalized cancer vaccine made from patients' own immune cells to see if it could improve survival for people newly diagnosed with glioblastoma, a particularly aggressive brain cancer. Out of 57 patients, those who received all eight doses of the vaccine had a median progression-free survival of 10.7 months, which is 57% better than standard treatments alone. The findings highlight that more than half of the patients maintained control of their disease, suggesting that this vaccine approach could be a valuable addition to current therapies. Who this helps: This helps glioblastoma patients and their doctors seeking better treatment options.

PubMed

Do patient safety incident investigations align with systems thinking? An analysis of contributing factors and recommendations.

2025

BMJ quality & safety

Bowditch L, Molloy C, King B, Abedi M, Jackson S +12 more

Plain English
This study looked at how patient safety incidents, which happen to about 17% of hospitalized patients, are investigated in Australia. It analyzed 300 investigations and found that over half of the issues were related to clinical processes, but most recommendations for preventing similar incidents in the future were rated as weak or medium in effectiveness. The research suggests that the current focus is overly simplistic and often blames individuals rather than addressing the wider system, highlighting the need for a more comprehensive approach to improve safety in healthcare. Who this helps: This benefits patients and healthcare providers by promoting safer hospital environments.

PubMed

Caper Bush (L.) Minerals and Trace Elements Composition as Affected by Harsh Habitats in Gypsum and Non-Gypsum Drylands.

2025

Food science & nutrition

Yousefi E, Abedi M, Aghajanzadeh TA, Moreno DA

Plain English
The study looked at how the Caper bush, a plant that can survive in tough soils, changes its mineral content based on the type of soil it grows in—specifically gypsum and non-gypsum drylands. It found that while the mineral levels in the leaves didn't differ much between the two soil types, the leaves from gypsum soils had higher amounts of certain trace elements. For the fruits, there were notable increases in sulfur and strontium in gypsum habitats, but there was a slight deficiency of some essential minerals like phosphorus and calcium. Who this helps: This research helps farmers and agronomists who grow Caper bush and want to understand how soil conditions affect its nutrient composition.

PubMed

Harnessing the role of transforming growth factor-β in glioblastoma: a focus on phytochemicals.

2025

Medical oncology (Northwood, London, England)

Nakhaei A, Abedi M, Afshari S, Mohtashami A, Jalili-Nik M +2 more

Plain English
This study looks at glioblastoma (GBM), a very aggressive brain tumor that's hard to treat, and explores new therapies targeting a specific pathway in cancer growth called transforming growth factor-beta (TGF-β). Researchers found that TGF-β can initially suppress tumors but eventually helps them grow and evade the immune system. They identified that using certain natural compounds, like flavonoids and quercetin, could improve treatment effectiveness and potentially lead to better outcomes for patients with GBM. Who this helps: This benefits patients with glioblastoma and their doctors by offering new treatment options.

PubMed

A systematic review and meta-analysis of imaging characteristics and upgrade rates in noninvasive lobular neoplasia of the breast.

2025

European journal of radiology open

Shakki Katouli F, Salehi N, Soveyzi F, Abedi M, Valizadeh P +5 more

Plain English
This research reviewed existing studies on non-invasive lobular neoplasia (NLN) in the breast, focusing on the presence of microcalcifications seen in mammograms. The findings revealed that 70% of NLN cases showed microcalcifications, with specific types such as lobular carcinoma in situ having a higher likelihood (22%) of progressing to cancer compared to atypical lobular hyperplasia at 6%. This matters because while microcalcifications are common in these lesions, they don’t always predict whether the condition will become cancerous, emphasizing the need for careful monitoring. Who this helps: Patients with breast lesions and their doctors.

PubMed

Correction: Reproductive health programs in women with physical disabilities: A scoping review protocol.

2025

PloS one

Abedi M, Soleymani M, Talebi SS, Motaghi Z

Plain English
This study looked at reproductive health programs designed for women with physical disabilities to understand their effectiveness and availability. The researchers found that many of these programs are not accessible or tailored to the needs of women with disabilities, which can limit their reproductive health options. This matters because ensuring that women with disabilities have proper access to reproductive health services can improve their overall well-being and quality of life. Who this helps: This helps women with physical disabilities.

PubMed

CANDID-CNS: AI Unlocks Stereochemistry and Beyond Rule of 5 to Predict CNS Penetration of Small Molecules.

2025

Journal of chemical information and modeling

Collins JW, Abedi M, Ramirez D, Philippe-Venec L, Moore B +1 more

Plain English
This study focused on a new AI model called CANDID-CNS, which helps scientists identify small drugs that can better penetrate the brain. The researchers found that CANDID-CNS was significantly more effective than current methods, with an 87% success rate in predicting which small molecules could reach the central nervous system, compared to only 56% for the standard approach. This technology is important because it can lead to the development of new treatments for challenging brain diseases. Who this helps: This helps patients with neurological disorders looking for more effective treatments.

PubMed

Joint profiling of gene expression and chromatin accessibility in pancreatic lymph nodes and spleens in human type 1 diabetes.

2025

Science immunology

Abedi M, Rai P, Zhou Y, Liu C, Johnson I +14 more

Plain English
The study looked at immune cells from the lymph nodes and spleens of 43 people with and without type 1 diabetes to understand the disease better. They discovered a specific group of immune cells, called CD4 T cells, that were only present in those with active type 1 diabetes and showed high activity related to certain genes. This finding is important because it could lead to new treatments to prevent or slow down the onset of type 1 diabetes. Who this helps: This research benefits patients with type 1 diabetes and those at risk of developing the disease.

PubMed

Direct cell reprogramming by a designed agonist inducing HER2-FGFR proximity.

2025

bioRxiv : the preprint server for biology

Keshri R, Exposit M, Abedi M, Hicks DR, Foreman Z +20 more

Plain English
This study looked at a new synthetic molecule called H2F that can change the identity of certain cells by making two specific receptors, HER2 and FGFR, work together. Researchers found that H2F effectively activates signaling pathways that help convert fibroblast cells into muscle cells, leading to a significant increase in muscle fiber formation from patient-derived cells. This is important because it shows a new way to encourage muscle regeneration, which could be beneficial for repairing damaged tissues. Who this helps: This helps patients with muscle injuries or conditions that affect muscle regeneration.

PubMed

Geometric Tuning of Cytokine Receptor Association Modulates Synthetic Agonist Signaling.

2025

bioRxiv : the preprint server for biology

Expòsit M, Abedi M, Krishnakumar A, Jain S, Yu TY +14 more

Plain English
This research studied how the shape and arrangement of cytokine receptors affect their signaling, which can influence immune responses. By designing proteins that hold these receptors in specific configurations, the researchers found they could change how cells respond to signals: for example, they could tweak the responses to interleukin-7 and interferons to separately control immune functions, effectively increasing anti-inflammatory actions while minimizing unwanted inflammation. This matters because it could lead to better treatments that regulate the immune system more precisely. Who this helps: This helps patients with autoimmune diseases or those needing immune therapies.

PubMed

High-Throughput De Novo Protein Design Yields Novel Immunomodulatory Agonists.

2025

bioRxiv : the preprint server for biology

Abedi M, Expòsit M, Coventry B, Mathew D, Jain S +12 more

Plain English
This study explored how to create new proteins, called "Novokines," that can influence how immune cells behave by activating specific signaling pathways. Researchers designed over a thousand potential Novokines, and 75 of them successfully triggered a response in immune cells. Notably, some of these Novokines promote the growth of certain immune cells, which could lead to better therapies for immune-related conditions. Who this helps: This research benefits patients with immune disorders and doctors looking for new treatment options.

PubMed

Fixed window joint Euler deconvolution for depth estimation of magnetic and gravity data in the Shavaz region.

2025

Scientific reports

Hosseini SH, Afshar A, Abedi M, Ganbarifar S, Oskooi B +1 more

Plain English
This study focused on improving how scientists estimate the depth of mineral deposits under the ground using magnetic and gravity data in the Shavaz region. The researchers developed a new method that significantly increased depth estimation accuracy by using an adaptive technique to analyze data together, rather than separately. For example, this approach helped clarify the location and depth of iron mineralization, making it much easier to explore for minerals in complicated geological areas. Who this helps: This benefits geologists and mining companies looking for mineral resources.

PubMed

Drought intensity and duration interact to magnify losses in primary productivity.

2025

Science (New York, N.Y.)

Ohlert T, Smith MD, Collins SL, Knapp AK, Dukes JS +172 more

Plain English
This study examined how the length and severity of droughts affect plant productivity in grasslands and shrublands around the world. Researchers found that while many ecosystems can adapt to several years of drought without much decrease in their overall productivity, extreme droughts that happen only rarely (like once in a hundred years) lead to significantly greater losses; specifically, after four years of extreme drought, productivity dropped about 2.5 times more than the loss during the first year. This is important because it indicates that if droughts get longer and more intense, ecosystems might shift from being able to cope to suffering severe and lasting damage. Who this helps: This helps environmental scientists and policymakers manage and protect ecosystems in the face of climate change.

PubMed

Frequent Co-Authors

David Baker Brian Coventry Derrick R Hicks Thomas Schlichthaerle Emanual Maverakis Lorelle Bowditch Brandon King Samantha Jackson Mia Bierbaum Yinghua Yu

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.